This symposium will highlight the specific challenges, opportunities and strategies for developing HIV and TB vaccines and demonstrate how EDCTP-funded research is trying to address these together with international partners, including through locally developed solutions. The session will also discuss common areas with other infectious diseases of relevance to sub-Saharan Africa and explore possibilities for cross-cutting coordination, knowledge sharing and learning through established networks and platforms. The session will close with audience input for a stimulating discussion on how future collaborative HIV and TB vaccine research can address the challenges and needs identified and how best to engage the relevant actors in order to build on progress to date and ensure the development of practical, accessible and affordable vaccines for sub-Saharan African populations.
Chairs: Prof. Tandakha Ndiaye Dieye Head of laboratories, Centre National de Transfsuion Sanguine (CNTS) Head of immunology unit, IRESSEF (Diamniadio) & Le Dantec Hospital President of the African Society for Immunodeficiencies (ASID) Secretary General of the Society of AIDS in Africa (SAA)
Mr Roger Tatoud Deputy Director (Vaccines), HIV Programmes and Advocacy, International AIDS Society (IAS)
Speakers: Dr Alvaro Borges Chief Medical Officer, Center for Vaccine Research, Statens Serum Institut
Dr Laure Stella Ghoma Linguissi Researcher, Fondation Congolaise pour la Recherche Médicale
Shingai Machingaidze Project Officer, EDCTP
Mrs Yolanda Moyo Senior Director Advocacy Policy and Research Preparedness, International AIDS Vaccine Initiative
Dr Eugene Rzagira Senior Scientist, MRC/UVRI & LSHTM Uganda Research Unit